NCT06690268Completed
Multimodal Model Predicts Recurrence
Multimodal Clinical-imaging-pathology-driven Artificial Intelligence Model for Predicting Postoperative Recurrence of Locally Advanced Gastric Cancer
Source: ClinicalTrials.gov · Last updated 15 Nov 2024
Brief summary (registry, in English)
This study focuses on developing an advanced model that combines clinical information, imaging, and pathology data to predict the likelihood of cancer returning after surgery in patients with locally advanced gastric cancer. By using artificial intelligence (AI), this model analyzes various data sources to create a more accurate prediction of recurrence risk, which can help doctors, patients, and families better understand the chances of recurrence. This AI-driven approach allows healthcare providers to make more informed decisions about personalized follow-up care and potential additional treatments to improve patient outcomes.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 93 (actual)
- First submitted
- 13 Nov 2024
- Start date
- 1 Jan 2022
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Qun Zhao
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06690268
What you commit to
- Study type: Observational
- Participants enrolled: 93
- From 1 Jan 2022 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- \*\*Inclusion Criteria:\*\*
- Patients diagnosed with locally advanced gastric cancer (Stage II or III).
- Patients who have undergone surgical resection for gastric cancer.
- Patients with complete clinical, imaging, and pathology data available for analysis.
- Age 18 years or older.
- Patients who provide informed consent to participate in the study.
- \*\*Exclusion Criteria:\*\*
- Patients with distant metastasis (Stage IV) at the time of diagnosis.
- Patients with incomplete or missing clinical, imaging, or pathology data.
- Patients who have received prior treatment for gastric cancer other than surgical resection.
- Patients with other concurrent malignancies.
- Patients who are unable or unwilling to comply with the study follow-up requirements.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Fourth Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.